Approximately 5 million Americans have dementia, and many receive psychiatric medications. Management of such patients is complex and controversial, and it has become apparent that all potential pharmacological therapies present risks.

Breaking News

Hospitals, doctors spurred to improve quality of care for fee-for-service beneficiaries
First codeine-based, extended-release, oral-suspension cough/cold treatment in U.S.
Study suggests need for FDA reassessment of safety, efficacy of devices for off-label use

Recent Headlines

Launch expected in third quarter of 2015
More work needed on preventing errors, injuries, accidents, and infections, experts say
New data offer first detailed look at Part D costs and services
First spray-dried fibrin sealant approved by the agency